Compounds > cyfluthrin

Page last updated: 2024-08-26

cyfluthrin and Bacterial Disease

cyfluthrin has been researched along with Bacterial Disease in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (75.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Bertrand, D; Fernandes, P; Pereira, D; Watkins, PB	1
Chahine, EB; El-Lababidi, RM; Karaoui, LR; Mansour, H	1
Ma, Z; Nilius, AM	1
Nord, CE; Sillerström, E; Wahlund, E	1
Appleman, MD; Citron, DM	1
Alder, JD; Ewing, P; Flamm, RK; Hernandez, L; Jarvis, K; Ma, Z; Meulbroek, J; Mitten, MJ; Mollison, K; Nilius, AM; Nukkala, M; Oleksijew, A; Or, YS; Paige, L; Tovcimak, A	1
Lawrence, LE	1

Reviews

3 review(s) available for cyfluthrin and Bacterial Disease

Article	Year
Cethromycin: a new ketolide antibiotic. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Community-Acquired Infections; Drug Interactions; Drug Resistance, Bacterial; Humans; Ketolides; Microbial Sensitivity Tests	2013
Cethromycin: A-195773, A-195773-0, A-1957730, Abbott-195773, ABT 773. Drugs in R&D, 2007, Volume: 8, Issue:2 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Dogs; Drug Interactions; Guinea Pigs; Humans; Ketolides; Macaca fascicularis; Male; Parasitic Diseases; Rats	2007
ABT-773 (Abbott Laboratories). Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clinical Trials as Topic; Erythromycin; Humans; Ketolides; Respiratory Tract Infections; Structure-Activity Relationship	2001

Other Studies

5 other study(ies) available for cyfluthrin and Bacterial Disease

Article	Year
Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics. Journal of medicinal chemistry, 2020, 06-25, Volume: 63, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Macrolides	2020
Ketolides: the future of the macrolides? Current opinion in pharmacology, 2002, Volume: 2, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Methyltransferases; Ribosomes	2002
In vitro activity of ABT-773 against anaerobic bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2000, Volume: 19, Issue:8 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests	2000
Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests	2001
Efficacies of ABT-773, a new ketolide, against experimental bacterial infections. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:9 Topics: Animals; Bacterial Infections; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Ketolides; Listeriosis; Lung Diseases; Male; Mice; Rats; Rats, Sprague-Dawley; Respiratory Tract Diseases; Staphylococcal Infections; Streptococcal Infections; Streptococcus pneumoniae; Treatment Outcome	2001